Try our Advanced Search for more refined results

Deals Rumor Mill: Innovent, Lime, HNA

By Adam Rhodes (October 15, 2018, 8:18 PM EDT) -- Innovent Biologics wants to raise as much as $422 million when it goes public in Hong Kong, Reuters reported early Monday. According to the report, the Chinese biotech firm set a HK$12.50 ($1.60) to HK$14 per share price range for the initial public offering. That range, the outlet's anonymous sources said, values the company at roughly $2 billion. According to the report, the offering, expected to price on Oct. 23, could be the biggest biotech listing in Hong Kong in 2018....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!